Skip to main content

Table 2 Clinical characteristics of cancer patients

From: Evaluation of miRNA-21 and CA-125 as a promising diagnostic biomarker in patients with ovarian cancer

 

N (50)

%

FIGO stage

I/II

30

60.0

III/IV

20

40.0

Histological type

Serous

20

40.0

Mucinous

14

28.0

Endometrioid

16

32.0

US

Bilateral

22

44.0

Multilocular

16

32.0

Solid

12

24.0

Metastasis

 − ve

34

68.0

 + ve

16

16.0